These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1795884)

  • 1. Dopaminergic innervation and binding in the rat cerebellum.
    Panagopoulos NT; Papadopoulos GC; Matsokis NA
    Neurosci Lett; 1991 Sep; 130(2):208-12. PubMed ID: 1795884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT; Matsokis NA; Valcana T
    J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of [3H]dopamine and [3H]spiperone binding in mouse cerebellum.
    Panagopoulos NT; Matsokis NA
    Gen Pharmacol; 1994 Jan; 25(1):131-7. PubMed ID: 7913071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic and pharmacologic characterization of dopamine binding in the mouse cerebellum and the effects of the reeler mutation.
    Panagopoulos N; Matsokis NA; Valcana T
    J Neurosci Res; 1988; 19(1):122-9. PubMed ID: 3343704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA; Bennett JP
    Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
    Bischoff S; Bittiger H; Krauss J
    Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 11. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum.
    Gredal O; Nielsen M
    J Neurochem; 1987 Feb; 48(2):364-9. PubMed ID: 3794711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of [3H]N-propylnorapomorphine binding in mouse striatum.
    Severson JA; Randall PK
    Brain Res; 1983 Nov; 279(1-2):295-8. PubMed ID: 6416612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS; Burt DR; Barraclough CA
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.